osiris therapeutics inc (OSIR:NASDAQ GM)

Financial Statements for osiris therapeutics inc (OSIR)

Currency in Millions of US Dollars	As of:	Dec 31 2009	Dec 31 2010	Dec 31 2011	Dec 31 2012	4 Year Trend
Revenues		44.5	43.2	42.4	11.8
TOTAL REVENUES		44.5	43.2	42.4	11.8
Cost of Goods Sold		63.3	23.6	19.7	16.7
GROSS PROFIT		-18.7	19.6	22.7	-4.9
Selling General & Admin Expenses, Total		8.8	6.5	6.1	6.3
OTHER OPERATING EXPENSES, TOTAL		8.8	6.5	6.1	6.3
OPERATING INCOME		-27.5	13.2	16.6	-11.2
Interest and Investment Income		0.4	--	--	--
Other Non-Operating Expenses, Total		--	0.2	0.1	0.0
Other Non-Operating Income (Expenses)		--	0.2	0.1	0.0
Gain (Loss) on Sale of Investments		0.9	--	--	--
Other Unusual Items, Total		--	--	-1.7	--
EBT, INCLUDING UNUSUAL ITEMS		-26.3	13.4	14.9	-11.1
Income Tax Expense		-2.7	0.2	0.0	0.0
Earnings from Continuing Operations		-23.6	13.1	14.9	-11.1
EARNINGS FROM DISCOUNTINUED OPERATIONS		38.1	--	--	--
NET INCOME		14.6	13.1	14.9	-11.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		14.6	13.1	14.9	-11.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		-23.6	13.1	14.9	-11.1

Report Data Issue

To contact OSIRIS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.